You may also like
Terumo Americas Holding, Inc. Aquires Harvest Technologies
Terumo Americas Holding, Inc., a U.S. subsidiary of Japan’s Terumo Corporation, one of the world’s leading medical device manufacturers with $3.4 billion in sales and operations in more than 160 nations, today announced that it has entered into a Stock Purchase Agreement to acquire all outstanding shares of Harvest Technologies Corporation, an innovative biotechnology company working to commercialize the world’s first point-of-care technology that allows physicians to derive highly concentrated autologous, adult stem cells from their patients in just 15 minutes.
Heparinized Blood Better Preserves Cellular Energy Charge and Vascular Functions of Intraoperatively Stored Saphenous Vein Grafts in Comparison to Isotonic Sodium-Chloride-Solution
Heparinized blood better preserves vascular contractile and endothelial functions of the saphenous vein graft.
Gelatin and Hydroxyethyl Starch, but not Albumin, Impair Hemostasis After Cardiac Surgery
We investigated the effect of postoperative administration of colloids on hemostasis in 45 patients after cardiac surgery.
